However, interest in GLP-1 drugs, particularly Ozempic, has also been fueled in part by social media discourse and ...

Nov. 12, 2024 – Most people taking GLP-1 drugs for weight loss or diabetes no longer need to stop taking them before elective surgery, according to new guidance from the American Society of ...

As open enrollment kicks off, employees may find an unpleasant surprise in their 2025 health insurance premiums. Increased ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...

Using data from Real Chemistry's IRIS platform—which consists of medical, hospital, and pharmacy claims as a primary data ...

The warning affects all treatments containing GLP-1 receptor agonists, including semaglutide ( Ozempic, Wegovy, Rybelsus ), ...

Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...

In a practice-changing guideline reversal, medical societies advised on Tuesday that most patients do not need to stop taking ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Poor bowel preparation also led to repeat colonoscopies for 18.9% of current GLP-1RA users, compared to 11.1% of controls ...